FDA Adverse Event Malfunction Summary report: N

ACCESS® FREE T4 REAGENT

MDR report key: 2120787 · Received June 10, 2011

Report

Report Number
2122870-2011-01804
Event Type
Malfunction
Date Received
June 10, 2011
Date of Event
May 6, 2011
Report Date
May 12, 2011
Manufacturer
BECKMAN COULTER, INC.
Product Code
CEC
PMA / PMN Number
K982250
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NE, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

EVALUATION AND TROUBLESHOOTING ACTIVITIES WERE CONDUCTED VIA TELEPHONE. BCI RECOMMENDED THAT THE CUSTOMER ESTABLISH A REFERENCE RANGE FOR FREE T4 (TO UPDATE THE RANGE THAT WAS CURRENTLY IN USE SINCE IT WAS UNKNOWN HOW THE CURRENT RANGE WAS ESTABLISHED).

Description of Event or Problem · 1

THE CUSTOMER CONTACTED BECKMAN COULTER, INC. (BCI) TO REPORT LOWER THAN EXPECTED RESULTS FOR FREE THYROXINE (FREE T4) FOR PATIENT SAMPLES ASSAYED USING THE ACCESS FREE T4 REAGENT ON AN ACCESS 2 IMMUNOASSAY SYSTEM. THE PATIENT RESULTS WERE REPORTED OUT OF THE LABORATORY. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT. IT IS CURRENTLY UNKNOWN THE NUMBER OF IMPACTED PATIENT SAMPLES. SEVERAL REQUESTS HAVE BEEN MADE TO THE CUSTOMER FOR PATIENT SAMPLE DATA. TO DATE, NO DATA HAVE BEEN RECEIVED FROM THE CUSTOMER. ALL QUALITY CONTROL RESULTS FOR FREE T4 WERE WITHIN THEIR RESPECTIVE RANGES. THE CUSTOMER WAS NOT EXPERIENCING ANY ISSUES WITH THE OTHER ASSAYS ON THE ANALYZER. FURTHER DISCUSSION WITH THE CUSTOMER REVEALED THAT THE REFERENCE RANGE IN USE AT THE TIME FOR FREE T4 WAS 0.8-1.8 NG/DL. THE CUSTOMER WAS NOT AWARE HOW THIS RANGE WAS DETERMINED FOR THEIR LABORATORY. BCI COMMUNICATED TO THE CUSTOMER THAT THE PUBLISHED RANGE IN THE BCI INSTRUCTIONS FOR USE FOR FREE T4 IS 0.61-1.12 NG/DL. BCI RECOMMENDED THAT THE CUSTOMER ESTABLISH A REFERENCE RANGE FOR FREE T4 OR TO REVIEW PUBLISHED REFERENCE RANGES TO COMPARE AGAINST THEIR CURRENT RANGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS® FREE T4 REAGENT FREE THYROXINE TEST SYSTEM CEC BECKMAN COULTER, INC. 018460

Patients

Seq Age Sex Outcome Treatment
1 ACCESS 2 IMMUNOASSAY SYSTEM